Post-Genomic Biomarker-Based Diagnostic Products are Projected To Grow From $100 Million in 2003 to $2 Billion by 2008

Research and Markets (researchandmarkets.com/reports/c8902) has announced the addition of Post-Genomic Biomarkers: Revolutionizing Drug Development and Diagnostics to their offering.

(PRWEB) November 10, 2004 -- Biomarkers are not new certainly their use in pharmaceutical, diagnostic, and biomedical R&D goes back several decades. So why has there been so much activity recently? For most of the latter half of the twentieth century, the appearance of a new biomarker was a relatively rare event. The rise of new genomic, proteomic, and metabonomic technologies during the past decade has provided a major acceleration in the rate of biomarker discovery and major improvement in the quality and utility of the resulting markers. The availability of these new-wave markers provides pharmaceutical companies important new opportunities for improving the time- and cost-efficiency of drug development, as well as providing diagnostic companies access to new assays that promise vast improvement in early disease detection, prognosis, and monitoring.

Post-Genomic Biomarkers: Revolutionizing Drug Development and Diagnostics Market Analysis Report provides deep insights into the evolution of this field, the technologies contributing to biomarker discovery and detection, emerging applications of new-wave biomarkers, and market trends. In addition, the Report presents a series of revealing interviews with key experts in this young and dynamic field, along with in-depth profiles of key companies contributing to the revolution.

This Report Will Help You
-Pinpoint the market potential of biomarkers with an examination of the projected market impact through 2008.
-Determine the competitive advantage of classical versus post-genomic biomarker technologies for discovery and detection through a comprehensive breakdown of the capabilities and limitations of both.
-Discover the commercial viability of biomarker technology platforms through a detailed breakdown of their widespread uses and applications.
-Gain reliable and thought provoking insights into the biomarkers area from dynamic interviews with authorities involved in this industry.Look inside 24 companies working within the biomarker field-including strengths and weaknesses, product pipelines, alliances, business strategies, and more.

Table of Contents
1 Executive Summary
2 Introduction
3 Technology Background
4 Market Considerations Underlying the Biomarker Revolution
5 Technologies for Discovering and Detecting Biomarkers
6 Biomarker Applications
7 Commercial Implications of Biomarkers
8 The Future of Biomarkers
9 Company Profiles
10 Interviews with Industry Experts
11 Bibliography

For more information visit http://www.researchandmarkets.com/reports/c8902

Laura Wood
Senior Manager
Research and Markets
press@researchandmarkets.com
Fax: +353 1 4100 980

###